- Home
- SYNX vs ADXN Comparison
SYNX vs ADXN Comparison
Compare SYNX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYNX | ADXN |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | Israel | Switzerland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 8.0M |
| IPO Year | 2023 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SYNX | ADXN |
|---|---|---|
| Price | $0.98 | $6.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 3.1K |
| Earning Date | 05-01-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.35 | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $5.57 |
| 52 Week High | $2.15 | $12.05 |
Technical Indicators
Market Signals| Indicator | SYNX | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 39.46 |
| Support Level | $0.93 | $5.57 |
| Resistance Level | $1.31 | $8.29 |
| Average True Range (ATR) | 0.09 | 0.47 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 21.27 | 20.29 |
Price Performance
Historical ComparisonAbout SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.